ES2690970T3 - Sorbente polimérico para eliminación de impurezas de sangre total y productos de sangre - Google Patents
Sorbente polimérico para eliminación de impurezas de sangre total y productos de sangre Download PDFInfo
- Publication number
- ES2690970T3 ES2690970T3 ES12732231.1T ES12732231T ES2690970T3 ES 2690970 T3 ES2690970 T3 ES 2690970T3 ES 12732231 T ES12732231 T ES 12732231T ES 2690970 T3 ES2690970 T3 ES 2690970T3
- Authority
- ES
- Spain
- Prior art keywords
- blood
- methacrylate
- polymer
- acrylate
- pentaerythritol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002594 sorbent Substances 0.000 title claims abstract description 64
- 239000010836 blood and blood product Substances 0.000 title claims abstract description 53
- 239000012535 impurity Substances 0.000 title description 2
- 210000004369 blood Anatomy 0.000 claims abstract description 125
- 239000008280 blood Substances 0.000 claims abstract description 125
- 229920000642 polymer Polymers 0.000 claims abstract description 90
- 239000011148 porous material Substances 0.000 claims abstract description 79
- 239000012530 fluid Substances 0.000 claims abstract description 52
- 229940125691 blood product Drugs 0.000 claims abstract description 48
- 239000000463 material Substances 0.000 claims abstract description 33
- TXBCBTDQIULDIA-UHFFFAOYSA-N 2-[[3-hydroxy-2,2-bis(hydroxymethyl)propoxy]methyl]-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(CO)(CO)COCC(CO)(CO)CO TXBCBTDQIULDIA-UHFFFAOYSA-N 0.000 claims abstract description 32
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims abstract description 22
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 claims abstract description 20
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 claims abstract description 20
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 claims abstract description 20
- -1 dimethacrylate Chemical compound 0.000 claims abstract description 20
- MPMBRWOOISTHJV-UHFFFAOYSA-N but-1-enylbenzene Chemical compound CCC=CC1=CC=CC=C1 MPMBRWOOISTHJV-UHFFFAOYSA-N 0.000 claims abstract description 18
- ZNAOFAIBVOMLPV-UHFFFAOYSA-N hexadecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(C)=C ZNAOFAIBVOMLPV-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000000203 mixture Substances 0.000 claims abstract description 14
- 238000000746 purification Methods 0.000 claims abstract description 13
- 239000000178 monomer Substances 0.000 claims abstract description 12
- IGGDKDTUCAWDAN-UHFFFAOYSA-N 1-vinylnaphthalene Chemical compound C1=CC=C2C(C=C)=CC=CC2=C1 IGGDKDTUCAWDAN-UHFFFAOYSA-N 0.000 claims abstract description 10
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 claims abstract description 10
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims abstract description 10
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 claims abstract description 10
- HJWLCRVIBGQPNF-UHFFFAOYSA-N prop-2-enylbenzene Chemical compound C=CCC1=CC=CC=C1 HJWLCRVIBGQPNF-UHFFFAOYSA-N 0.000 claims abstract description 10
- NZIDBRBFGPQCRY-UHFFFAOYSA-N octyl 2-methylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C(C)=C NZIDBRBFGPQCRY-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000007787 solid Substances 0.000 claims abstract description 9
- MZTJZHXVZYABQR-UHFFFAOYSA-N 1,1,2,2,3-pentakis(ethenyl)cyclohexane Chemical compound C(=C)C1C(C(CCC1)(C=C)C=C)(C=C)C=C MZTJZHXVZYABQR-UHFFFAOYSA-N 0.000 claims abstract description 7
- WVAFEFUPWRPQSY-UHFFFAOYSA-N 1,2,3-tris(ethenyl)benzene Chemical compound C=CC1=CC=CC(C=C)=C1C=C WVAFEFUPWRPQSY-UHFFFAOYSA-N 0.000 claims abstract description 7
- MYWOJODOMFBVCB-UHFFFAOYSA-N 1,2,6-trimethylphenanthrene Chemical compound CC1=CC=C2C3=CC(C)=CC=C3C=CC2=C1C MYWOJODOMFBVCB-UHFFFAOYSA-N 0.000 claims abstract description 7
- DAKWPKUUDNSNPN-UHFFFAOYSA-N Trimethylolpropane triacrylate Chemical compound C=CC(=O)OCC(CC)(COC(=O)C=C)COC(=O)C=C DAKWPKUUDNSNPN-UHFFFAOYSA-N 0.000 claims abstract description 7
- OKKRPWIIYQTPQF-UHFFFAOYSA-N Trimethylolpropane trimethacrylate Chemical compound CC(=C)C(=O)OCC(CC)(COC(=O)C(C)=C)COC(=O)C(C)=C OKKRPWIIYQTPQF-UHFFFAOYSA-N 0.000 claims abstract description 7
- CQHKDHVZYZUZMJ-UHFFFAOYSA-N [2,2-bis(hydroxymethyl)-3-prop-2-enoyloxypropyl] prop-2-enoate Chemical compound C=CC(=O)OCC(CO)(CO)COC(=O)C=C CQHKDHVZYZUZMJ-UHFFFAOYSA-N 0.000 claims abstract description 7
- TUOBEAZXHLTYLF-UHFFFAOYSA-N [2-(hydroxymethyl)-2-(prop-2-enoyloxymethyl)butyl] prop-2-enoate Chemical compound C=CC(=O)OCC(CO)(CC)COC(=O)C=C TUOBEAZXHLTYLF-UHFFFAOYSA-N 0.000 claims abstract description 7
- JUDXBRVLWDGRBC-UHFFFAOYSA-N [2-(hydroxymethyl)-3-(2-methylprop-2-enoyloxy)-2-(2-methylprop-2-enoyloxymethyl)propyl] 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(CO)(COC(=O)C(C)=C)COC(=O)C(C)=C JUDXBRVLWDGRBC-UHFFFAOYSA-N 0.000 claims abstract description 7
- HVVWZTWDBSEWIH-UHFFFAOYSA-N [2-(hydroxymethyl)-3-prop-2-enoyloxy-2-(prop-2-enoyloxymethyl)propyl] prop-2-enoate Chemical compound C=CC(=O)OCC(CO)(COC(=O)C=C)COC(=O)C=C HVVWZTWDBSEWIH-UHFFFAOYSA-N 0.000 claims abstract description 7
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 claims abstract description 7
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 claims abstract description 7
- GQPVFBDWIUVLHG-UHFFFAOYSA-N [2,2-bis(hydroxymethyl)-3-(2-methylprop-2-enoyloxy)propyl] 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(CO)(CO)COC(=O)C(C)=C GQPVFBDWIUVLHG-UHFFFAOYSA-N 0.000 claims abstract description 5
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims description 24
- 102000001554 Hemoglobins Human genes 0.000 claims description 23
- 108010054147 Hemoglobins Proteins 0.000 claims description 23
- 108090000695 Cytokines Proteins 0.000 claims description 12
- 102000004127 Cytokines Human genes 0.000 claims description 12
- 229940065472 octyl acrylate Drugs 0.000 claims description 9
- ANISOHQJBAQUQP-UHFFFAOYSA-N octyl prop-2-enoate Chemical compound CCCCCCCCOC(=O)C=C ANISOHQJBAQUQP-UHFFFAOYSA-N 0.000 claims description 9
- 210000003743 erythrocyte Anatomy 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 7
- 239000012528 membrane Substances 0.000 claims description 7
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 7
- 239000000047 product Substances 0.000 claims description 7
- 239000004793 Polystyrene Substances 0.000 claims description 6
- 229920002223 polystyrene Polymers 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 239000000427 antigen Substances 0.000 claims description 5
- 108091007433 antigens Proteins 0.000 claims description 5
- 102000036639 antigens Human genes 0.000 claims description 5
- 210000004027 cell Anatomy 0.000 claims description 5
- 150000002632 lipids Chemical class 0.000 claims description 5
- 108090000288 Glycoproteins Proteins 0.000 claims description 4
- 102000003886 Glycoproteins Human genes 0.000 claims description 4
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 claims description 4
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims description 4
- 102000029797 Prion Human genes 0.000 claims description 4
- 108091000054 Prion Proteins 0.000 claims description 4
- ATMLPEJAVWINOF-UHFFFAOYSA-N acrylic acid acrylic acid Chemical compound OC(=O)C=C.OC(=O)C=C ATMLPEJAVWINOF-UHFFFAOYSA-N 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 230000002757 inflammatory effect Effects 0.000 claims description 4
- LKIPOGBWSIFYFM-UHFFFAOYSA-N n,n-bis(ethenyl)formamide Chemical compound C=CN(C=C)C=O LKIPOGBWSIFYFM-UHFFFAOYSA-N 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 claims description 4
- 229920000098 polyolefin Polymers 0.000 claims description 4
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 claims description 4
- UDJZTGMLYITLIQ-UHFFFAOYSA-N 1-ethenylpyrrolidine Chemical compound C=CN1CCCC1 UDJZTGMLYITLIQ-UHFFFAOYSA-N 0.000 claims description 3
- MHHJQVRGRPHIMR-UHFFFAOYSA-N 1-phenylprop-2-en-1-ol Chemical compound C=CC(O)C1=CC=CC=C1 MHHJQVRGRPHIMR-UHFFFAOYSA-N 0.000 claims description 3
- SJIXRGNQPBQWMK-UHFFFAOYSA-N 2-(diethylamino)ethyl 2-methylprop-2-enoate Chemical compound CCN(CC)CCOC(=O)C(C)=C SJIXRGNQPBQWMK-UHFFFAOYSA-N 0.000 claims description 3
- QHVBLSNVXDSMEB-UHFFFAOYSA-N 2-(diethylamino)ethyl prop-2-enoate Chemical compound CCN(CC)CCOC(=O)C=C QHVBLSNVXDSMEB-UHFFFAOYSA-N 0.000 claims description 3
- GNSFRPWPOGYVLO-UHFFFAOYSA-N 3-hydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCO GNSFRPWPOGYVLO-UHFFFAOYSA-N 0.000 claims description 3
- QZPSOSOOLFHYRR-UHFFFAOYSA-N 3-hydroxypropyl prop-2-enoate Chemical compound OCCCOC(=O)C=C QZPSOSOOLFHYRR-UHFFFAOYSA-N 0.000 claims description 3
- 108010012236 Chemokines Proteins 0.000 claims description 3
- 102000019034 Chemokines Human genes 0.000 claims description 3
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 claims description 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical class CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 3
- 229920001311 Poly(hydroxyethyl acrylate) Polymers 0.000 claims description 3
- 229920002845 Poly(methacrylic acid) Polymers 0.000 claims description 3
- 239000002202 Polyethylene glycol Substances 0.000 claims description 3
- 229920002125 Sokalan® Polymers 0.000 claims description 3
- 229920001577 copolymer Polymers 0.000 claims description 3
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 claims description 3
- 229920000669 heparin Polymers 0.000 claims description 3
- 229960002897 heparin Drugs 0.000 claims description 3
- PZDUWXKXFAIFOR-UHFFFAOYSA-N hexadecyl prop-2-enoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C=C PZDUWXKXFAIFOR-UHFFFAOYSA-N 0.000 claims description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 3
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 claims description 3
- 239000004800 polyvinyl chloride Substances 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 239000003053 toxin Substances 0.000 claims description 3
- 231100000765 toxin Toxicity 0.000 claims description 3
- 108700012359 toxins Proteins 0.000 claims description 3
- 238000012546 transfer Methods 0.000 claims description 3
- CGJJXMJPCMSTCG-UHFFFAOYSA-N 2,2-bis(hydroxymethyl)propane-1,3-diol;2-methylprop-2-enoic acid Chemical compound CC(=C)C(O)=O.CC(=C)C(O)=O.OCC(CO)(CO)CO CGJJXMJPCMSTCG-UHFFFAOYSA-N 0.000 claims description 2
- HVAUUPRFYPCOCA-AREMUKBSSA-N 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCOC[C@@H](OC(C)=O)COP([O-])(=O)OCC[N+](C)(C)C HVAUUPRFYPCOCA-AREMUKBSSA-N 0.000 claims description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical class OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 2
- 101800004538 Bradykinin Proteins 0.000 claims description 2
- 241000157855 Cinchona Species 0.000 claims description 2
- 235000001258 Cinchona calisaya Nutrition 0.000 claims description 2
- 102000009025 Endorphins Human genes 0.000 claims description 2
- 108010049140 Endorphins Proteins 0.000 claims description 2
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 claims description 2
- 102000014150 Interferons Human genes 0.000 claims description 2
- 108010050904 Interferons Proteins 0.000 claims description 2
- 102100035792 Kininogen-1 Human genes 0.000 claims description 2
- 108010050619 Monokines Proteins 0.000 claims description 2
- 102000013967 Monokines Human genes 0.000 claims description 2
- 102000035195 Peptidases Human genes 0.000 claims description 2
- 108091005804 Peptidases Proteins 0.000 claims description 2
- 108010003541 Platelet Activating Factor Proteins 0.000 claims description 2
- 229920001054 Poly(ethylene‐co‐vinyl acetate) Polymers 0.000 claims description 2
- 239000004365 Protease Substances 0.000 claims description 2
- LGEQQWMQCRIYKG-DOFZRALJSA-N anandamide Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCO LGEQQWMQCRIYKG-DOFZRALJSA-N 0.000 claims description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical class CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims description 2
- LGEQQWMQCRIYKG-UHFFFAOYSA-N arachidonic acid ethanolamide Natural products CCCCCC=CCC=CCC=CCC=CCCCC(=O)NCCO LGEQQWMQCRIYKG-UHFFFAOYSA-N 0.000 claims description 2
- 239000011230 binding agent Substances 0.000 claims description 2
- 230000000975 bioactive effect Effects 0.000 claims description 2
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 claims description 2
- 210000003850 cellular structure Anatomy 0.000 claims description 2
- 230000000295 complement effect Effects 0.000 claims description 2
- 239000007857 degradation product Substances 0.000 claims description 2
- 239000002158 endotoxin Substances 0.000 claims description 2
- 239000003102 growth factor Substances 0.000 claims description 2
- 229960001340 histamine Drugs 0.000 claims description 2
- 239000000367 immunologic factor Substances 0.000 claims description 2
- 229940047124 interferons Drugs 0.000 claims description 2
- 150000002617 leukotrienes Chemical class 0.000 claims description 2
- 239000003446 ligand Substances 0.000 claims description 2
- 229940094443 oxytocics prostaglandins Drugs 0.000 claims description 2
- 239000004014 plasticizer Substances 0.000 claims description 2
- 150000003180 prostaglandins Chemical class 0.000 claims description 2
- 125000003410 quininyl group Chemical group 0.000 claims description 2
- FNKQXYHWGSIFBK-RPDRRWSUSA-N sapropterin Chemical compound N1=C(N)NC(=O)C2=C1NC[C@H]([C@@H](O)[C@@H](O)C)N2 FNKQXYHWGSIFBK-RPDRRWSUSA-N 0.000 claims description 2
- 229960004617 sapropterin Drugs 0.000 claims description 2
- 229940076279 serotonin Drugs 0.000 claims description 2
- 231100000617 superantigen Toxicity 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 150000003595 thromboxanes Chemical class 0.000 claims description 2
- UAXOELSVPTZZQG-UHFFFAOYSA-N trimethyl acrylic acid Chemical compound CC(C)=C(C)C(O)=O UAXOELSVPTZZQG-UHFFFAOYSA-N 0.000 claims description 2
- 230000002227 vasoactive effect Effects 0.000 claims description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 2
- 229920002554 vinyl polymer Polymers 0.000 claims description 2
- 101100289061 Drosophila melanogaster lili gene Proteins 0.000 claims 4
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 claims 2
- DPBJAVGHACCNRL-UHFFFAOYSA-N 2-(dimethylamino)ethyl prop-2-enoate Chemical compound CN(C)CCOC(=O)C=C DPBJAVGHACCNRL-UHFFFAOYSA-N 0.000 claims 2
- 229920000249 biocompatible polymer Polymers 0.000 claims 2
- 101150013553 CD40 gene Proteins 0.000 claims 1
- 102000016289 Cell Adhesion Molecules Human genes 0.000 claims 1
- 108010067225 Cell Adhesion Molecules Proteins 0.000 claims 1
- 206010018910 Haemolysis Diseases 0.000 claims 1
- 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 claims 1
- 230000004888 barrier function Effects 0.000 claims 1
- 230000000994 depressogenic effect Effects 0.000 claims 1
- 238000003795 desorption Methods 0.000 claims 1
- 239000002270 dispersing agent Substances 0.000 claims 1
- 230000008588 hemolysis Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 210000004379 membrane Anatomy 0.000 claims 1
- 230000002107 myocardial effect Effects 0.000 claims 1
- 238000004458 analytical method Methods 0.000 description 17
- 239000004005 microsphere Substances 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 11
- 238000001179 sorption measurement Methods 0.000 description 11
- 238000005534 hematocrit Methods 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- RYCNUMLMNKHWPZ-SNVBAGLBSA-N 1-acetyl-sn-glycero-3-phosphocholine Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C RYCNUMLMNKHWPZ-SNVBAGLBSA-N 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 230000032683 aging Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 101710124165 1-acyl-sn-glycerol-3-phosphate acyltransferase Proteins 0.000 description 4
- 101710097496 Lysophospholipid acyltransferase Proteins 0.000 description 4
- 101710163746 Lysophospholipid acyltransferase 2 Proteins 0.000 description 4
- 102100038805 Lysophospholipid acyltransferase 2 Human genes 0.000 description 4
- 239000004372 Polyvinyl alcohol Substances 0.000 description 4
- 101710172946 Probable 1-acyl-sn-glycerol-3-phosphate acyltransferase Proteins 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 210000000265 leukocyte Anatomy 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000004342 Benzoyl peroxide Substances 0.000 description 3
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 3
- 102000018832 Cytochromes Human genes 0.000 description 3
- 108010052832 Cytochromes Proteins 0.000 description 3
- 102000008100 Human Serum Albumin Human genes 0.000 description 3
- 108091006905 Human Serum Albumin Proteins 0.000 description 3
- 108010002586 Interleukin-7 Proteins 0.000 description 3
- 108090001007 Interleukin-8 Proteins 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 108700012920 TNF Proteins 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 208000003441 Transfusion reaction Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 235000019400 benzoyl peroxide Nutrition 0.000 description 3
- 210000001772 blood platelet Anatomy 0.000 description 3
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 208000020406 Creutzfeldt Jacob disease Diseases 0.000 description 2
- 208000003407 Creutzfeldt-Jakob Syndrome Diseases 0.000 description 2
- 208000010859 Creutzfeldt-Jakob disease Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 206010072266 Transfusion-associated dyspnoea Diseases 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 229940098197 human immunoglobulin g Drugs 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 229940072221 immunoglobulins Drugs 0.000 description 2
- 238000009434 installation Methods 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 235000010288 sodium nitrite Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- HOELAYIBVDJXPO-UHFFFAOYSA-N 5-(dimethylamino)-2-methylpent-2-enoic acid prop-2-enoic acid Chemical compound CN(C)CCC=C(C(=O)O)C.C(C=C)(=O)O HOELAYIBVDJXPO-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
- 108010029697 CD40 Ligand Proteins 0.000 description 1
- 102100032937 CD40 ligand Human genes 0.000 description 1
- 235000005956 Cosmos caudatus Nutrition 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 1
- 206010067122 Haemolytic transfusion reaction Diseases 0.000 description 1
- 108090000174 Interleukin-10 Proteins 0.000 description 1
- 108010065805 Interleukin-12 Proteins 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 108090000978 Interleukin-4 Proteins 0.000 description 1
- 108010002616 Interleukin-5 Proteins 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 208000004852 Lung Injury Diseases 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 108010050608 Myocardial Depressant Factor Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102100027701 Roundabout homolog 4 Human genes 0.000 description 1
- 206010071090 Transfusion related complication Diseases 0.000 description 1
- 206010069363 Traumatic lung injury Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 206010069351 acute lung injury Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 239000003114 blood coagulation factor Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 230000033077 cellular process Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 230000004992 fission Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 229940027941 immunoglobulin g Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 231100000515 lung injury Toxicity 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000006461 physiological response Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- XYKIUTSFQGXHOW-UHFFFAOYSA-N propan-2-one;toluene Chemical compound CC(C)=O.CC1=CC=CC=C1 XYKIUTSFQGXHOW-UHFFFAOYSA-N 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000010557 suspension polymerization reaction Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/14—Mechanical aspects of preservation; Apparatus or containers therefor
- A01N1/146—Non-refrigerated containers specially adapted for transporting or storing living parts whilst preserving
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/16—Physical preservation processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/26—Synthetic macromolecular compounds
- B01J20/265—Synthetic macromolecular compounds modified or post-treated polymers
- B01J20/267—Cross-linked polymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28002—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their physical properties
- B01J20/28004—Sorbent size or size distribution, e.g. particle size
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28054—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their surface properties or porosity
- B01J20/28069—Pore volume, e.g. total pore volume, mesopore volume, micropore volume
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28054—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their surface properties or porosity
- B01J20/28078—Pore diameter
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3202—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the carrier, support or substrate used for impregnation or coating
- B01J20/3206—Organic carriers, supports or substrates
- B01J20/3208—Polymeric carriers, supports or substrates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3268—Macromolecular compounds
- B01J20/327—Polymers obtained by reactions involving only carbon to carbon unsaturated bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3268—Macromolecular compounds
- B01J20/3272—Polymers obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3268—Macromolecular compounds
- B01J20/328—Polymers on the carrier being further modified
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49826—Assembling or joining
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- External Artificial Organs (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161430374P | 2011-01-06 | 2011-01-06 | |
| US201161430374P | 2011-01-06 | ||
| US13/344,166 US10064406B2 (en) | 2011-01-06 | 2012-01-05 | Polymeric sorbent for removal of impurities from whole blood and blood products |
| US201213344166 | 2012-01-05 | ||
| PCT/US2012/020429 WO2012094565A1 (en) | 2011-01-06 | 2012-01-06 | Polymeric sorbent for removal of impurities from whole blood and blood products |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2690970T3 true ES2690970T3 (es) | 2018-11-23 |
Family
ID=46457720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES12732231.1T Active ES2690970T3 (es) | 2011-01-06 | 2012-01-06 | Sorbente polimérico para eliminación de impurezas de sangre total y productos de sangre |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10064406B2 (enExample) |
| EP (1) | EP2665358B1 (enExample) |
| JP (1) | JP5946469B2 (enExample) |
| CN (2) | CN109847403A (enExample) |
| AU (1) | AU2012204271B2 (enExample) |
| CA (1) | CA2823953C (enExample) |
| ES (1) | ES2690970T3 (enExample) |
| WO (1) | WO2012094565A1 (enExample) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107260755A (zh) | 2010-04-01 | 2017-10-20 | 西托索尔本茨公司 | 治疗炎症的方法 |
| KR101819688B1 (ko) | 2010-11-12 | 2018-01-17 | 코어 파마슈티칼스 디벨롭먼트 컴퍼니 | 변형된 면역-조절 입자 |
| EP2741605B1 (en) * | 2011-08-12 | 2020-06-17 | Cytosorbents Corporation | Polymeric sorbent for removal of impurities from whole blood and blood products |
| US9993389B2 (en) | 2011-09-19 | 2018-06-12 | Fenwal, Inc. | Red blood cell products and the storage of red blood cells in containers free of phthalate plasticizer |
| KR20220166879A (ko) | 2012-06-21 | 2022-12-19 | 노쓰웨스턴유니버시티 | 펩티드 접합된 입자 |
| EP3673930B1 (en) * | 2012-06-29 | 2024-10-30 | Cytosorbents Corporation | Biocompatible sorbent |
| IL303425A (en) | 2013-03-13 | 2023-08-01 | Cour Pharmaceuticals Dev Company | Secondary vaccine particles for the treatment of inflammation |
| US10398625B2 (en) | 2013-03-13 | 2019-09-03 | Fenwal, Inc. | Medical containers with terephthalate plasticizer for storing red blood cell products |
| CA2908202A1 (en) * | 2013-04-01 | 2014-10-09 | Cytosorbents Corporation | Hemocompatibility modifiers for cross-linked polymeric material |
| CN103230781A (zh) * | 2013-05-03 | 2013-08-07 | 重庆大学 | 一种用于血液净化法去除内毒素的肝素-苯丙氨酸吸附材料 |
| MX372849B (es) | 2013-08-13 | 2020-07-06 | Univ Northwestern | Partículas conjugadas con péptidos. |
| WO2015113699A1 (en) * | 2014-01-30 | 2015-08-06 | Fresenius Hemocare Italia Srl | Filtering device |
| KR20160125389A (ko) | 2014-02-20 | 2016-10-31 | 프레제니우스 헤모케어 네덜란드 비.브이. | 적혈구 제품, 혈장 및 혈소판의 보관을 위한 비-dehp 가소제를 갖는 의료용 컨테이너 및 시스템 구성요소 |
| US20170266362A1 (en) | 2014-08-26 | 2017-09-21 | 3M Innovative Properties Company | System for removal of pro-inflammatory mediators as well as granulocytes and monocytes from blood |
| WO2016054458A1 (en) * | 2014-10-02 | 2016-04-07 | Cytosorbents Corporation | Use of gastroinstestinally administered porous enteron sorbent polymers to prevent or treat radiation induced mucositis, esophagitis, enteritis, colitis, and gastrointestinal acute radiation syndrome |
| US9522971B2 (en) * | 2014-12-31 | 2016-12-20 | Chung Yuan Christian University | Amine modifying material and application thereof |
| RU2619864C2 (ru) * | 2015-06-30 | 2017-05-18 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Псковский государственный университет" | Способ получения полимерного гемосорбента |
| CA3001698C (en) | 2015-10-22 | 2025-01-07 | Cytosorbents Corporation | Sorbant in the form of porous, blood-compatible polymer beads, multifunctional for the elimination of protein-based toxins and potassium from biological fluids |
| CN105749886A (zh) * | 2016-04-08 | 2016-07-13 | 华南理工大学 | 血液灌流器医用高分子微球吸附剂及其制备方法 |
| CN105959752A (zh) * | 2016-04-29 | 2016-09-21 | 镇江惠通电子有限公司 | 终端与遥控终端的适配方法、装置及遥控终端 |
| WO2017205720A1 (en) | 2016-05-26 | 2017-11-30 | Drexel University | Open surface graphitic materials for adsorption of cytokines from blood |
| CA3025321A1 (en) * | 2016-05-26 | 2017-11-30 | Cytosorbents Corporation | The use of a hemocompatible porous polymer bead sorbent for removal of endotoxemia-inducing molecules |
| CN106334540B (zh) * | 2016-10-09 | 2018-07-31 | 南开大学 | 一种用于血液或血浆灌流去除内毒素的吸附剂及其制备方法 |
| CN107126936B (zh) * | 2017-04-17 | 2020-07-17 | 天津大学 | 一种带有包埋材料的血液净化吸附剂及制备方法 |
| BR112019024483A2 (pt) * | 2017-05-23 | 2020-06-16 | Cytosorbents Corporation | Método de tratamento de lesão cerebral traumática |
| RU2653125C1 (ru) * | 2017-05-23 | 2018-05-07 | Акционерное общество "ПЕРСПЕКТИВНЫЕ МЕДИЦИНСКИЕ ТЕХНОЛОГИИ" | Полимерный сорбент, способ его получения и использования |
| CN108608088B (zh) * | 2018-07-13 | 2024-06-21 | 广西广协智能科技有限公司 | 一种冷藏回温锡膏柜 |
| CN110237569A (zh) * | 2019-07-10 | 2019-09-17 | 嘉兴市北加州电子科技有限责任公司 | 一种液相分离装置及应用 |
| JP2023522173A (ja) * | 2020-04-07 | 2023-05-29 | サイトソーベンツ・コーポレーション | 血液および毒素濾過装置とその使用方法 |
| CN111811996B (zh) * | 2020-05-29 | 2022-10-04 | 深圳市帝迈生物技术有限公司 | 白细胞分类试剂盒及其制备方法、染料废液处理方法 |
| CN113926010B (zh) * | 2021-10-11 | 2023-08-29 | 山东威高血液净化制品股份有限公司 | 一种用于中空纤维血液净化装置体外测试的全血模拟液 |
| CN114073865B (zh) * | 2022-01-17 | 2022-11-25 | 深圳市达科为生物工程有限公司 | 去除血清中外泌体的方法及过滤装置 |
| CN114950383B (zh) * | 2022-04-08 | 2024-02-06 | 淄博康贝医疗器械有限公司 | 血液净化用细胞因子吸附剂及制备方法 |
| CN117696017B (zh) * | 2024-02-05 | 2024-05-07 | 四川大学华西医院 | 一种血液净化吸附改性材料及其制备方法 |
Family Cites Families (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4064042A (en) * | 1975-02-18 | 1977-12-20 | Rohm And Haas Company | Purification of blood using partially pyrolyzed polymer particles |
| US4272894A (en) * | 1979-03-21 | 1981-06-16 | Salviati Impianti S.P.A. | Drying step in a method of producing ceramic articles |
| DE2929959A1 (de) * | 1979-07-24 | 1981-02-19 | Hoechst Ag | Thermoplastische kunststoffmasse |
| JPS58170717A (ja) * | 1982-03-31 | 1983-10-07 | Teiji Tsuruta | B細胞の分離材および分離器ならびに分離方法 |
| NL8301035A (nl) | 1983-03-23 | 1984-10-16 | Organon Teknika Bv | Macromoleculair materiaal met carbonylgroepen geschikt als sorbent voor stikstofverbindingen. |
| JPS6361007A (ja) * | 1986-08-30 | 1988-03-17 | Res Dev Corp Of Japan | 金属錯体尿素分解樹脂及び尿素分解剤 |
| JP2732252B2 (ja) * | 1987-12-07 | 1998-03-25 | 株式会社ジェイ・エム・エス | ヘモグロビン選択吸着剤 |
| JPH01189346A (ja) | 1988-01-22 | 1989-07-28 | Tokyo Organ Chem Ind Ltd | β↓2−ミクログロブリン吸着体 |
| JPH01200918A (ja) * | 1988-02-06 | 1989-08-14 | Nagaharu Kawamoto | 発泡樹脂による断熱層形成用型枠並びに断熱層形成方法 |
| JP3208132B2 (ja) * | 1990-11-30 | 2001-09-10 | テルモ株式会社 | 血液成分分離方法 |
| JP2726170B2 (ja) * | 1991-05-09 | 1998-03-11 | 帝人株式会社 | 変性セルロース系ポリマー、血液処理器及びその製造方法 |
| US5211850A (en) * | 1991-07-26 | 1993-05-18 | Research Medical, Inc. | Plasma filter sorbent system for removal of components from blood |
| JPH0558707A (ja) | 1991-09-06 | 1993-03-09 | Art Ceramic Kk | 廃棄物を利用した人工石又はタイルの製造法 |
| JP2822718B2 (ja) | 1991-09-26 | 1998-11-11 | 松下電器産業株式会社 | データ処理装置及びデータ処理方法 |
| US5217743A (en) * | 1992-02-07 | 1993-06-08 | Paradigm Biotechnologies Partnership | Biomaterials of enhanced biocompatibility |
| JP3246681B2 (ja) | 1992-10-16 | 2002-01-15 | 旭メディカル株式会社 | トランスサイレチン吸着剤 |
| ATE246028T1 (de) * | 1995-12-26 | 2003-08-15 | Asahi Medical Co | Filtrationsmittel zum entfernen von leukocyten |
| JP3313572B2 (ja) | 1996-04-03 | 2002-08-12 | ヘモネティクス・コーポレーション | 血液処理用遠心分離器ボウル |
| US20010018179A1 (en) | 1998-01-06 | 2001-08-30 | Derek J. Hei | Batch devices for the reduction of compounds from biological compositions containing cells and methods of use |
| US6416487B1 (en) | 1997-07-30 | 2002-07-09 | Renal Tech International Llc | Method of removing beta-2 microglobulin from blood |
| CA2317430A1 (en) | 1998-01-06 | 1999-07-15 | Cerus Corporation | Flow devices for the reduction of compounds from biological compositions and methods of use |
| JPH11290662A (ja) | 1998-04-14 | 1999-10-26 | Nof Corp | 中空糸膜及びその製造方法 |
| AU1923200A (en) | 1999-01-22 | 2000-08-07 | Dow Chemical Company, The | Surface modified divinylbenzene resin having a hemocompatible coating |
| EP1148063A1 (de) * | 2000-04-18 | 2001-10-24 | Octapharma AG | Haemostatisch aktives vWF enthaltendes Präparat und Verfahren zu seiner Herstellung |
| EP1884274A1 (en) | 2000-12-29 | 2008-02-06 | Upfront Chromatography A/S | Extracorporeal capturing of specific bio-macromolecular entities from extracellular body fluids |
| WO2002060557A1 (en) * | 2001-01-29 | 2002-08-08 | Asahi Medical Co., Ltd. | Filter for processing blood and process for producing the same |
| US20020197252A1 (en) * | 2001-04-10 | 2002-12-26 | Renal Tech International | Selective adsorption devices and systems |
| WO2003078023A1 (en) | 2002-03-14 | 2003-09-25 | Baxter International Inc. | Compound removal device |
| US20050176678A1 (en) | 2002-05-09 | 2005-08-11 | Roland Horres | Compounds and method for coating surfaces in a haemocompatibe manner |
| US7255895B2 (en) | 2003-01-21 | 2007-08-14 | Bioarray Solutions, Ltd. | Method for controlling solute loading of polymer microparticles |
| JP5391520B2 (ja) | 2006-02-21 | 2014-01-15 | 東レ株式会社 | 改質基材の製造方法 |
| JP5027591B2 (ja) | 2006-08-18 | 2012-09-19 | 株式会社カネカ | 架橋ポリマー粒子およびその製法 |
| US7875182B2 (en) | 2006-11-20 | 2011-01-25 | Cytosorbents, Inc. | Size-selective hemoperfusion polymeric adsorbents |
| US8211310B2 (en) * | 2006-11-20 | 2012-07-03 | Cytosorbents, Inc. | Size-selective polymer system |
| US9033908B2 (en) | 2006-12-21 | 2015-05-19 | Nederlandse Organisatie Voor Toegepast—Natuurwetenschappelijk Onderzoek Tno | Device for the removal of toxic substances from blood |
| CN100469692C (zh) * | 2006-12-29 | 2009-03-18 | 上海师范大学 | 含氮有序介孔碳及其合成方法 |
| EP2217646B1 (en) * | 2007-11-09 | 2013-01-23 | 3M Innovative Properties Company | Porous polymeric resins |
| JP2009125265A (ja) | 2007-11-22 | 2009-06-11 | Kaneka Corp | サイトカイン吸着材 |
| JP2009165667A (ja) | 2008-01-16 | 2009-07-30 | Asahi Kasei Medical Co Ltd | プリオン除去機能を有するフィルター |
| JP2009178523A (ja) * | 2008-02-01 | 2009-08-13 | Kaneka Corp | 可溶性腫瘍壊死因子受容体の吸着材、吸着方法および吸着装置 |
| CN101279242A (zh) | 2008-05-20 | 2008-10-08 | 大连理工大学 | 用于抗体清除的血液净化吸附剂 |
| US20110210074A1 (en) | 2008-06-26 | 2011-09-01 | Winchester James F | Removal of myoglobin from blood and/or physiological fluids |
| JP5349873B2 (ja) | 2008-09-04 | 2013-11-20 | 大阪有機化学工業株式会社 | 医療用材料 |
| US20100210989A1 (en) | 2008-12-23 | 2010-08-19 | Janet Lesley Macpherson | Processing blood |
| JP5341559B2 (ja) | 2009-03-03 | 2013-11-13 | 和雄 寺本 | 多孔性吸着材 |
| AU2010234916A1 (en) * | 2009-03-30 | 2011-10-13 | Cerulean Pharma Inc. | Polymer-agent conjugates, particles, compositions, and related methods of use |
| JP6126167B2 (ja) | 2015-07-02 | 2017-05-10 | 日立マクセル株式会社 | デジタルコンテンツ受信装置、および、デジタルコンテンツ受信方法 |
-
2012
- 2012-01-05 US US13/344,166 patent/US10064406B2/en active Active
- 2012-01-06 EP EP12732231.1A patent/EP2665358B1/en active Active
- 2012-01-06 CN CN201811229100.6A patent/CN109847403A/zh active Pending
- 2012-01-06 JP JP2013548563A patent/JP5946469B2/ja active Active
- 2012-01-06 AU AU2012204271A patent/AU2012204271B2/en not_active Ceased
- 2012-01-06 WO PCT/US2012/020429 patent/WO2012094565A1/en not_active Ceased
- 2012-01-06 ES ES12732231.1T patent/ES2690970T3/es active Active
- 2012-01-06 CN CN201280004791.4A patent/CN103533830A/zh active Pending
- 2012-01-06 CA CA2823953A patent/CA2823953C/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2823953C (en) | 2023-01-03 |
| CN109847403A (zh) | 2019-06-07 |
| CN103533830A (zh) | 2014-01-22 |
| WO2012094565A1 (en) | 2012-07-12 |
| CA2823953A1 (en) | 2012-07-12 |
| JP2014502971A (ja) | 2014-02-06 |
| EP2665358A4 (en) | 2014-06-25 |
| EP2665358A1 (en) | 2013-11-27 |
| EP2665358B1 (en) | 2018-08-29 |
| AU2012204271B2 (en) | 2015-08-13 |
| JP5946469B2 (ja) | 2016-07-06 |
| US20130011824A1 (en) | 2013-01-10 |
| US10064406B2 (en) | 2018-09-04 |
| AU2012204271A1 (en) | 2013-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2690970T3 (es) | Sorbente polimérico para eliminación de impurezas de sangre total y productos de sangre | |
| US12208116B2 (en) | Multi-functional hemocompatible porous bead sorbent for removing protein based toxins and potassium from biological fluids | |
| ES2806075T3 (es) | Sorbente polimérico para la eliminación de impurezas de sangre completa y productos sanguíneos | |
| JP4958554B2 (ja) | リンパ球増殖抑制因子の吸着材及び処理方法 | |
| JP6126327B2 (ja) | IgM型抗体吸着用吸着材及びIgM型抗体除去システム |